ALLO Allogene Therapeutics, Inc. - Common Stock
ALLO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
ALLO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
ALLO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 6 33,3%
- Compra 10 55,6%
- Mantener 2 11,1%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
9 analistas · 2026-08-15Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.13 | $-0.17 | 0.04% |
| 31 de marzo de 2026 | $-0.18 | $-0.19 | 0.01% |
| 31 de diciembre de 2025 | $-0.17 | $-0.22 | 0.05% |
| 30 de septiembre de 2025 | $-0.19 | $-0.23 | 0.04% |
| 30 de junio de 2025 | $-0.23 | $-0.28 | 0.05% |
| 31 de marzo de 2025 | $-0.28 | $-0.30 | 0.02% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| NGNE | $319M | -4.9 | — | — | -33.6% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| EIKN | — | — | — | — | — | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22.0K | $95.0K | $156.0K | $114M | $0 | $0 | |
| R&D Expense | $150M | $192M | $243M | $256M | $220M | $193M | $145M | |
| SG&A Expense | $57M | $65M | $72M | $79M | $74M | $65M | $57M | |
| Operating Expenses | $209M | $273M | $328M | $336M | $294M | $258M | $202M | |
| Operating Income | $-209M | $-273M | $-328M | $-336M | $-180M | $-258M | $-202M | |
| Interest Expense | · | · | · | · | · | $0 | $0 | |
| Other Non-op | $215.0K | $-4M | $-18M | $-9M | $-4M | $-67M | $17M | |
| Pretax Income | $-191M | $-257M | $-327M | · | $-257M | $-250M | $-185M | |
| Income Tax | $0 | $443.0K | $0 | $0 | $0 | $0 | $-331.0K | |
| Net Income | $-191M | $-258M | $-327M | $-340M | $-182M | $-316M | $-185M | |
| EPS (Basic) | $-0.87 | $-1.32 | $-2.09 | $-2.38 | $-1.34 | $-2.63 | $-1.83 | |
| EPS (Diluted) | $-0.87 | $-1.32 | $-2.09 | $-2.38 | $-1.34 | $-2.63 | $-1.83 | |
| Shares (Basic) | 220,622,669 | 194,811,756 | 156,931,778 | 143,147,165 | 135,820,386 | 120,370,177 | 101,061,149 | |
| Shares (Diluted) | 220,622,669 | 194,811,756 | 156,931,778 | 143,147,165 | 135,820,386 | 120,370,177 | 101,061,149 | |
| EBITDA | $-197M | $-260M | $-314M | · | $-245M | $-251M | $-197M |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $52M | $75M | $83M | $62M | $173M | $183M | $175M | |
| Short-term Investments | · | · | · | · | $284M | $645M | $355M | |
| Prepaid Expense | $8M | $11M | $10M | $12M | $14M | $17M | $14M | |
| Current Assets | $258M | $303M | $459M | $529M | $471M | $845M | $545M | |
| PP&E (Net) | $73M | $86M | $99M | $113M | $123M | $119M | $56M | |
| PP&E (Gross) | $145M | $149M | $151M | $150M | $146M | $132M | $62M | |
| Accum. Depreciation | $73M | $63M | $51M | $37M | $23M | $13M | $5M | |
| Intangibles | · | · | · | · | · | $0 | $151.0K | |
| Other Non-current Assets | $4M | $2M | $7M | $10M | $6M | $5M | $5M | |
| Total Assets | $416M | $549M | $643M | $822M | $1.05B | $1.23B | $718M | |
| Accounts Payable | $4M | $5M | $6M | $14M | $10M | $10M | $9M | |
| Current Liabilities | $33M | $36M | $37M | $54M | $48M | $94M | $33M | |
| Capital Leases | $75M | $83M | $88M | $95M | $70M | $51M | $51M | |
| Other Non-current Liabilities | $16M | $8M | $5M | $6M | $8M | $3M | $4M | |
| Total Liabilities | $123M | $127M | $131M | $155M | $126M | $148M | $89M | |
| Common Stock | $229.0K | $212.0K | $169.0K | $144.0K | $142.0K | $140.0K | $124.0K | |
| Retained Earnings | $-2.01B | $-1.82B | $-1.56B | $-1.23B | $-895M | $-713M | $-396M | |
| AOCI | $269.0K | $-89.0K | $-955.0K | $-10M | $-3M | $268.0K | $1M | |
| Stockholders' Equity | $293M | $422M | $512M | $667M | $925M | $1.01B | $629M | |
| Liabilities + Equity | $416M | $549M | $643M | $822M | $1.05B | $1.23B | $718M | |
| Shares Outstanding | 229,413,523 | 212,210,597 | 168,642,238 | 144,438,304 | 142,623,065 | 140,474,305 | 124,267,358 |
Flujo de Efectivo 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $14M | $14M | $14M | $10M | $7M | $5M | |
| Stock-based Comp | $38M | $52M | $66M | $84M | $81M | $65M | $46M | |
| Deferred Tax | $0 | $443.0K | $0 | · | · | · | · | |
| Amort. of Intangibles | · | · | · | $0 | $0 | $151.0K | $603.0K | |
| Restructuring | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-8M | $-9M | $9M | · | $-19M | $62M | $-3M | |
| Operating Cash Flow | $-149M | $-200M | $-238M | $-221M | $-185M | $-115M | $-137M | |
| CapEx | $386.0K | $694.0K | $2M | $5M | $21M | $66M | $51M | |
| Investing Cash Flow | $96M | $76M | $163M | $106M | $164M | $-505M | $164M | |
| Stock Issued | · | · | $91M | $0 | $0 | $596M | $0 | |
| Net Stock Activity | · | · | $91M | · | $0 | $622M | $54M | |
| Financing Cash Flow | $30M | $117M | $96M | $3M | $12M | $634M | $59M | |
| Net Change in Cash | $-24M | $-8M | $21M | $-111M | $-9M | $13M | $86M | |
| Free Cash Flow | $-150M | $-201M | $-239M | · | $-206M | $-181M | $-188M | |
| Levered FCF | · | · | · | · | · | $-181M | $-188M |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1241813.6% | -344986.3% | · | -664.6% | · | · | |
| Net Margin | · | -1170863.6% | -344489.5% | · | -667.7% | · | · | |
| Pretax Margin | · | -1168850.0% | · | · | -667.7% | · | · | |
| EBITDA Margin | · | -1179818.2% | -330039.0% | · | -637.3% | · | · | |
| ROA | -39.6% | -43.2% | -48.3% | · | -22.7% | -25.7% | -24.8% | |
| ROE | -59.9% | -58.1% | -59.9% | · | -27.3% | -22.8% | -29.6% | |
| ROIC | -71.5% | -64.8% | · | · | -27.9% | -23.9% | -32.1% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 8.5 | 12.4 | · | 9.8 | 9.0 | 16.5 | |
| Quick Ratio | 1.6 | 2.1 | 2.2 | · | 9.5 | 8.8 | 16.0 |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · |
Tasas de Crecimiento 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -76.8% | -39.1% | -99.9% | · | · | · | |
| Revenue CAGR 3Y | · | -94.2% | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $22.0K | $95.0K | $156.0K | $114M | $0 | $0 | |
| Net Income TTM | $-191M | $-258M | $-327M | $-340M | $-182M | $-316M | $-185M | |
| Market Cap | $314M | $452M | $541M | · | $2.13B | $3.55B | $3.23B | |
| P/E | -1.6 | -1.6 | -1.5 | -2.6 | -11.1 | -9.6 | -14.2 | |
| P/S | · | 20545.8 | 5698.3 | · | 18.7 | · | · | |
| P/B | 1.1 | 1.1 | 1.1 | · | 2.3 | 3.3 | 5.1 | |
| P / Tangible Book | 1.1 | 1.1 | 1.1 | 1.4 | 2.3 | 3.5 | · | |
| P / Cash Flow | -2.1 | -2.3 | -2.3 | · | -11.5 | -30.8 | -23.5 | |
| P / FCF | -2.1 | -2.2 | -2.3 | · | -10.3 | -19.6 | -17.2 | |
| Earnings Yield | -63.5% | -62.0% | -65.1% | -37.8% | -9.0% | -10.4% | -7.0% |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $22.0K | $21.0K | $22.0K | $22.0K | $30.0K | $-40.0K | $27.0K | |
| R&D Expense | $31M | $32M | $29M | $31M | $40M | $50M | $45M | $45M | $50M | $52M | $55M | $46M | $62M | $80M | $75M | $64M | |
| SG&A Expense | $21M | $14M | $14M | $14M | $14M | $15M | $16M | $16M | $16M | $17M | $17M | $17M | $19M | $19M | $21M | $19M | |
| Operating Expenses | $52M | $46M | $42M | $45M | $57M | $65M | $60M | $72M | $71M | $70M | $85M | $63M | $81M | $99M | $96M | $83M | |
| Operating Income | $-47M | $-46M | $-42M | $-45M | $-57M | $-65M | $-60M | $-72M | $-71M | $-70M | $-85M | $-63M | $-81M | $-99M | $-96M | $-83M | |
| Other Non-op | $-61.0K | $212.0K | $247.0K | $-81.0K | $-43.0K | $92.0K | $-2M | $-1M | $85.0K | $-929.0K | $-12M | $-5M | $-2M | $2M | $-10M | $-3M | |
| Net Income | $-43M | $-43M | $-39M | $-41M | $-51M | $-60M | $-60M | $-66M | $-66M | $-65M | $-86M | $-62M | $-79M | $-100M | $-103M | $-84M | |
| EPS (Basic) | $-0.13 | $-0.18 | $-0.17 | $-0.19 | $-0.23 | $-0.28 | $-0.27 | $-0.32 | $-0.35 | $-0.38 | $-0.49 | $-0.37 | $-0.54 | $-0.69 | $-0.72 | $-0.59 | |
| EPS (Diluted) | $-0.13 | $-0.18 | $-0.17 | $-0.19 | $-0.23 | $-0.28 | $-0.27 | $-0.32 | $-0.35 | $-0.38 | $-0.49 | $-0.37 | $-0.54 | $-0.69 | $-0.72 | $-0.59 | |
| Shares (Basic) | 328,930,269 | 240,290,782 | -435,704,178 | 222,038,680 | 218,929,548 | 215,358,619 | -373,531,795 | 209,188,551 | 190,026,638 | 169,128,362 | -302,076,887 | 167,649,010 | 146,795,826 | 144,563,829 | -285,255,907 | 143,661,721 | |
| Shares (Diluted) | 328,930,269 | 240,290,782 | -435,704,178 | 222,038,680 | 218,929,548 | 215,358,619 | -373,531,795 | 209,188,551 | 190,026,638 | 169,128,362 | -302,076,887 | 167,649,010 | 146,795,826 | 144,563,829 | -285,255,907 | 143,661,721 | |
| EBITDA | $-47M | $-43M | · | $-45M | $-57M | $-62M | · | $-72M | $-71M | $-70M | · | $-63M | $-81M | $-99M | · | $-82M |
Balance general 19
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $39M | $30M | $52M | $38M | $52M | $42M | $75M | $51M | $171M | $51M | $83M | $69M | $155M | $110M | $62M | $74M | |
| Prepaid Expense | $7M | $6M | $8M | $9M | $10M | $12M | $11M | $13M | $12M | $11M | $10M | $8M | $10M | $10M | $12M | $17M | |
| Current Assets | $340M | $273M | $258M | $261M | $283M | $292M | $303M | $304M | $457M | $395M | $459M | $473M | $502M | $481M | $529M | $569M | |
| PP&E (Net) | $67M | $70M | $73M | $76M | $79M | $83M | $86M | $89M | $92M | $96M | $99M | $103M | $106M | $110M | $113M | $114M | |
| PP&E (Gross) | $145M | $145M | $145M | $145M | $146M | $149M | $149M | $149M | $148M | $151M | $151M | $150M | $150M | $150M | $150M | $149M | |
| Accum. Depreciation | $78M | $75M | $73M | $70M | $67M | $66M | $63M | $60M | $56M | $55M | $51M | $48M | $44M | $40M | $37M | $35M | |
| Other Non-current Assets | $4M | $4M | $4M | $4M | $4M | $2M | $2M | $5M | $6M | $5M | $7M | $10M | $9M | $9M | $10M | $9M | |
| Total Assets | $550M | $396M | $416M | $440M | $471M | $508M | $549M | $589M | $647M | $586M | $643M | $712M | $771M | $747M | $822M | $888M | |
| Accounts Payable | $6M | $5M | $4M | $4M | $5M | $5M | $5M | $6M | $13M | $6M | $6M | $6M | $10M | $15M | $14M | $11M | |
| Current Liabilities | $32M | $28M | $33M | $32M | $32M | $30M | $36M | $33M | $37M | $31M | $37M | $38M | $55M | $60M | $54M | $49M | |
| Capital Leases | $70M | $73M | $75M | $77M | $79M | $81M | $83M | $85M | $87M | $89M | $88M | $90M | $92M | $94M | $95M | $97M | |
| Other Non-current Liabilities | $12M | $16M | $16M | $15M | $15M | $11M | $8M | $8M | $8M | $5M | $5M | $1M | $2M | $2M | $6M | $2M | |
| Total Liabilities | $114M | $117M | $123M | $124M | $126M | $123M | $127M | $125M | $132M | $125M | $131M | $129M | $148M | $155M | $155M | $148M | |
| Common Stock | $345.0K | $245.0K | $229.0K | $223.0K | $220.0K | $219.0K | $212.0K | $210.0K | $209.0K | $170.0K | $169.0K | $168.0K | $167.0K | $146.0K | $144.0K | $144.0K | |
| Retained Earnings | $-2.10B | $-2.05B | $-2.01B | $-1.97B | $-1.93B | $-1.88B | $-1.82B | $-1.76B | $-1.69B | $-1.63B | $-1.56B | $-1.47B | $-1.41B | $-1.33B | $-1.23B | $-1.14B | |
| AOCI | $-518.0K | $-183.0K | $269.0K | $235.0K | $-45.0K | $43.0K | $-89.0K | $157.0K | $-780.0K | $-927.0K | $-955.0K | $-2M | $-4M | $-6M | $-10M | $-13M | |
| Stockholders' Equity | $436M | $279M | $293M | $315M | $345M | $385M | $422M | $464M | $515M | $461M | $512M | $583M | $623M | $592M | $667M | $740M | |
| Liabilities + Equity | $550M | $396M | $416M | $440M | $471M | $508M | $549M | $589M | $647M | $586M | $643M | $712M | $771M | $747M | $822M | $888M | |
| Shares Outstanding | 345,345,427 | 244,816,413 | 229,413,523 | 223,163,672 | 220,133,876 | 218,598,262 | 212,210,597 | 209,500,137 | 209,049,485 | 170,452,967 | 168,642,238 | 168,175,221 | 167,133,664 | 145,740,333 | 144,438,304 | 144,031,588 |
Flujo de Efectivo 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $4M | · | · | · | · | |
| Stock-based Comp | $12M | $8M | $8M | $9M | $9M | $12M | $13M | $13M | $14M | $12M | $15M | $15M | $17M | $19M | $17M | $21M | |
| Restructuring | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $19M | · | · | · | $-8M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-32M | $-13M | $-28M | $-30M | $-39M | $-53M | $-37M | $-44M | $-64M | $-56M | $-54M | $-56M | $-62M | $-67M | $-62M | $-48M | |
| CapEx | $150.0K | $9.0K | $0 | $243.0K | $44.0K | $99.0K | $257.0K | $429.0K | $0 | $8.0K | $181.0K | $12.0K | $288.0K | $1M | $2M | $223.0K | |
| Investing Cash Flow | $-148M | $-30M | $34M | $12M | $44M | $6M | $55M | $-76M | $75M | $22M | $67M | $-34M | $17M | $113M | $50M | $25M | |
| Stock Issued | · | · | · | · | · | $10M | · | · | · | $0 | · | $3M | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $10M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $188M | $21M | $8M | $3M | $5M | $14M | $6M | $679.0K | $109M | $2M | $155.0K | $4M | $90M | $2M | $46.0K | $1M | |
| Net Change in Cash | $8M | $-21M | $14M | $-15M | $10M | $-33M | $24M | $-119M | $120M | $-32M | $14M | $-86M | $45M | $48M | $-12M | $-22M | |
| Free Cash Flow | · | $-13M | · | · | · | $-53M | · | · | · | $-56M | · | · | · | $-68M | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1011.2% | · | · | · | · | · | · | · | · | -315927.3% | · | -146453.5% | -182995.5% | -190519.2% | · | -168344.9% | |
| Net Margin | -919.8% | · | · | · | · | · | · | · | · | -295454.6% | · | -142593.0% | -177247.7% | -189815.4% | · | -169689.8% | |
| EBITDA Margin | -1011.2% | · | · | · | · | · | · | · | · | -315927.3% | · | -146453.5% | -182995.5% | -190519.2% | · | -168344.9% | |
| ROA | -8.4% | -9.4% | · | -8.1% | -9.1% | -10.9% | · | -10.2% | -9.4% | -9.8% | · | -7.7% | -9.1% | -11.5% | · | -8.5% | |
| ROE | -10.9% | -12.8% | · | -10.6% | -11.8% | -14.1% | · | -12.7% | -11.7% | -12.3% | · | -9.3% | -10.9% | -13.6% | · | -9.7% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.7 | 9.6 | · | 8.2 | 8.9 | 9.7 | · | 9.3 | 12.3 | 12.8 | · | 12.6 | 9.2 | 8.1 | · | 11.6 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.2 | 1.7 | 1.4 | · | 1.6 | 4.6 | 1.7 | · | 1.8 | 2.8 | 1.8 | · | 1.5 |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | · | $0 | $0 | $22.0K | · | $44.0K | $66.0K | $96.0K | · | $101.0K | $143.0K | $160.0K | · | $179.0K | |
| Net Income TTM | $-178M | $-195M | · | $-218M | $-243M | $-257M | · | $-260M | $-273M | $-306M | · | $-326M | $-344M | $-343M | · | $-321M | |
| Market Cap | $718M | $597M | · | $277M | $249M | $319M | · | $587M | $487M | $762M | · | $533M | $831M | $720M | · | $1.56B | |
| P/E | -2.8 | -2.8 | · | -1.2 | -1.0 | -1.1 | · | -2.0 | -1.4 | -2.3 | · | -1.4 | -2.1 | -2.1 | · | -4.7 | |
| P/S | · | · | · | · | · | 14507.0 | · | 13331.8 | 7380.1 | 7936.7 | · | 5278.4 | 5808.8 | 4499.7 | · | 8690.2 | |
| P/B | 1.6 | 2.1 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | 0.9 | 1.7 | · | 0.9 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 1.6 | 2.1 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | 0.9 | 1.7 | · | 0.9 | 1.3 | 1.2 | · | 2.1 | |
| P / Cash Flow | · | -46.3 | · | · | · | -6.0 | · | · | · | -13.6 | · | · | · | -10.8 | · | · | |
| P / FCF | · | -46.2 | · | · | · | -6.0 | · | · | · | -13.6 | · | · | · | -10.6 | · | · | |
| Earnings Yield | -35.1% | -36.1% | · | -82.3% | -104.4% | -91.1% | · | -50.7% | -70.4% | -44.3% | · | -69.1% | -47.9% | -48.6% | · | -21.1% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Ingresos | $0 | $22.0K | $95.0K | — | — |
| Margen Operativo % | — | -1241813.6% | -344986.3% | — | — |
| Beneficio neto | $-191M | $-258M | $-327M | — | — |
| EPS Diluido | $-0.87 | $-1.32 | $-2.09 | — | — |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Ratio corriente | 7.9 | 8.5 | 12.4 | — | — |
| Ratio Rápido | 1.6 | 2.1 | 2.2 | — | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-150M | $-201M | $-239M | — | — |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 231 declarantes · $530.0M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 37 (-15 vs trimestre anterior) | 25 (+14 vs trimestre anterior) | 90 (+13 vs trimestre anterior) | 55 (+12 vs trimestre anterior) | +113.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Pfizer Inc | $46 928 245 | 22 032 040 | 8,85% | Acciones |
| Frazier Life Sciences Management, L.P. | $46 689 069 | 22 446 668 | 8,81% | Acciones |
| STATE STREET CORP | $39 573 718 | 19 025 826 | 7,47% | Acciones |
| TPG GP A, LLC | $38 929 916 | 18 716 306 | 7,34% | Acciones |
| Sio Capital Management, LLC | $27 712 736 | 13 323 431 | 5,23% | Acciones |
| PRIMECAP MANAGEMENT CO/CA/ | $27 296 756 | 13 123 440 | 5,15% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $25 306 603 | 12 166 636 | 4,77% | Acciones |
| FMR LLC | $24 957 776 | 11 998 931 | 4,71% | Acciones |
| CITADEL ADVISORS LLC | $19 676 871 | 9 460 034 | 3,71% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $16 191 444 | 7 784 348 | 3,05% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $12 494 150 | 6 005 150 | 2,36% | Acciones |
| GOLDMAN SACHS GROUP INC | $12 467 422 | 5 993 953 | 2,35% | Acciones |
| VANGUARD GROUP INC | $11 178 392 | 8 159 410 | 2,11% | Acciones |
| GordonMD Global Investments LP | $11 019 840 | 5 298 000 | 2,08% | Acciones |
| Patient Square Capital LP | $10 504 000 | 5 050 000 | 1,98% | Acciones |
| Aberdeen Group plc | $10 403 644 | 5 001 752 | 1,96% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $10 075 289 | 4 843 889 | 1,90% | Acciones |
| Woodline Partners LP | $9 361 298 | 4 500 624 | 1,77% | Acciones |
| Candriam S.C.A. | $9 010 818 | 4 336 296 | 1,70% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 761 122 | 4 212 078 | 1,65% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $7 975 369 | 3 834 312 | 1,50% | Acciones |
| Walleye Capital LLC | $6 797 465 | 3 268 012 | 1,28% | Acciones |
| RTW INVESTMENTS, LP | $6 760 000 | 3 250 000 | 1,28% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $6 397 849 | 3 075 889 | 1,21% | Acciones |
| Ghisallo Capital Management LLC | $6 240 000 | 3 000 000 | 1,18% | Acciones |
| Wildcat Capital Management, LLC | $6 075 237 | 2 920 787 | 1,15% | Acciones |
| BANK OF AMERICA CORP /DE/ | $6 043 750 | 2 905 649 | 1,14% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 730 675 | 2 274 363 | 0,89% | Acciones |
| DAFNA Capital Management LLC | $4 160 000 | 2 000 000 | 0,78% | Acciones |
| TWO SIGMA ADVISERS, LP | $3 959 574 | 2 890 200 | 0,75% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $3 823 756 | 1 838 344 | 0,72% | Acciones |
| Boxer Capital Management, LLC | $3 120 000 | 1 500 000 | 0,59% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3 026 614 | 1 455 103 | 0,57% | Acciones |
| Raiffeisen Bank International AG | $2 442 000 | 1 100 000 | 0,46% | Acciones |
| Vida Ventures Advisors, LLC | $2 229 722 | 1 798 163 | 0,42% | Acciones |
| BlackRock, Inc. | $2 142 876 | 1 030 229 | 0,40% | Acciones |
| Man Group plc | $1 459 954 | 701 901 | 0,28% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $1 412 262 | 678 972 | 0,27% | Acciones |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1 138 153 | 547 189 | 0,21% | Acciones |
| CITIGROUP INC | $1 038 914 | 499 478 | 0,20% | Acciones |
| Voleon Capital Management LP | $1 010 092 | 485 621 | 0,19% | Acciones |
| AMERIPRISE FINANCIAL INC | $977 182 | 469 799 | 0,18% | Acciones |
| TD Asset Management Inc | $961 126 | 462 080 | 0,18% | Acciones |
| MACKENZIE FINANCIAL CORP | $893 489 | 429 562 | 0,17% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $886 650 | 426 274 | 0,17% | Acciones |
| Erste Asset Management GmbH | $846 708 | 381 400 | 0,16% | Acciones |
| ALPS ADVISORS INC | $728 630 | 350 303 | 0,14% | Acciones |
| Rafferty Asset Management, LLC | $702 073 | 337 535 | 0,13% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $666 114 | 320 247 | 0,13% | Acciones |
| RHUMBLINE ADVISERS | $644 248 | 309 741 | 0,12% | Acciones |
| Moloney Securities Asset Management, LLC | $637 360 | 514 000 | 0,12% | Acciones |
| Harold Davidson & Associates Inc. | $585 566 | 281 522 | 0,11% | Acciones |
| IEQ CAPITAL, LLC | $582 257 | 279 931 | 0,11% | Acciones |
| Bank of New York Mellon Corp | $558 216 | 268 373 | 0,11% | Acciones |
| HSBC HOLDINGS PLC | $557 157 | 259 747 | 0,11% | Acciones |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $554 147 | 266 417 | 0,10% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $551 142 | 225 878 | 0,10% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $520 000 | 250 000 | 0,10% | Acciones |
| Squarepoint Ops LLC | $502 370 | 241 524 | 0,09% | Acciones |
| UBS Group AG | $494 220 | 237 606 | 0,09% | Acciones |
| BIT Capital GmbH | $478 400 | 230 000 | 0,09% | Acciones |
| WELLS FARGO & COMPANY/MN | $462 342 | 222 280 | 0,09% | Acciones |
| LPL Financial LLC | $458 994 | 220 670 | 0,09% | Acciones |
| Vanguard Global Advisers, LLC | $447 585 | 215 185 | 0,08% | Acciones |
| CAXTON ASSOCIATES LP | $439 589 | 206 380 | 0,08% | Acciones |
| Quadrature Capital Ltd | $437 825 | 210 493 | 0,08% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $431 400 | 207 404 | 0,08% | Acciones |
| Headlands Technologies LLC | $427 342 | 205 453 | 0,08% | Acciones |
| BARCLAYS PLC | $383 836 | 184 536 | 0,07% | Acciones |
| OpenArc Corporate Advisory, LLC | $362 457 | 174 258 | 0,07% | Acciones |
| CWM, LLC | $359 063 | 147 157 | 0,07% | Acciones |
| Virtus Investment Advisers, LLC | $358 195 | 172 209 | 0,07% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $354 432 | 170 400 | 0,07% | Opción de compra |
| PROFUND ADVISORS LLC | $352 972 | 169 698 | 0,07% | Acciones |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | $336 122 | 161 597 | 0,06% | Acciones |
| WINTON GROUP Ltd | $328 973 | 158 160 | 0,06% | Acciones |
| MetLife Investment Management, LLC | $324 844 | 156 175 | 0,06% | Acciones |
| Smartleaf Asset Management LLC | $306 080 | 137 874 | 0,06% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $305 000 | 146 779 | 0,06% | Acciones |
| JPMORGAN CHASE & CO | $291 295 | 131 214 | 0,05% | Acciones |
| MARSHALL WACE, LLP | $290 479 | 139 653 | 0,05% | Acciones |
| CHOREO, LLC | $260 129 | 125 062 | 0,05% | Acciones |
| ALGERT GLOBAL LLC | $254 634 | 122 420 | 0,05% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $254 234 | 122 228 | 0,05% | Acciones |
| Quantbot Technologies LP | $243 221 | 116 933 | 0,05% | Acciones |
| CANADA PENSION PLAN INVESTMENT BOARD | $240 240 | 115 500 | 0,05% | Acciones |
| Graham Capital Management, L.P. | $237 992 | 114 419 | 0,04% | Acciones |
| Invesco Ltd. | $215 130 | 103 428 | 0,04% | Acciones |
| Engineers Gate Manager LP | $204 903 | 98 511 | 0,04% | Acciones |
| BANK OF NOVA SCOTIA | $202 592 | 97 400 | 0,04% | Acciones |
| Xcelsior Advisor Partners LLC | $199 661 | 95 991 | 0,04% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $194 773 | 93 641 | 0,04% | Acciones |
| AXQ CAPITAL, LP | $173 091 | 83 217 | 0,03% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $171 392 | 82 400 | 0,03% | Opción de venta |
| Mariner, LLC | $167 681 | 80 616 | 0,03% | Acciones |
| CAPTRUST FINANCIAL ADVISORS | $164 730 | 79 197 | 0,03% | Acciones |
| MORGAN STANLEY | $164 104 | 78 896 | 0,03% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $162 822 | 78 280 | 0,03% | Acciones |
| D. E. Shaw & Co., Inc. | $157 196 | 75 575 | 0,03% | Acciones |
| CITADEL ADVISORS LLC | $149 344 | 71 800 | 0,03% | Opción de compra |
Informantes de la empresa 16 insiders · 6 directivos · 8 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Zachary Roberts | President and CEO | 1 de julio de 2026 A | — | 0 | 0 | $0 |
| David D Chang | President and CEO | 23 de marzo de 2022 A | 2 289 652 | 0 | 0 | $0 |
| Eric Thomas Schmidt | Chief Financial Officer | 23 de marzo de 2022 A | 337 904 | 0 | 0 | $0 |
| Rafael Amado | EVP of R&D and CMO | 21 de junio de 2022 S | 544 257 | 0 | 0 | $0 |
| Veer Bhavnagri | General Counsel | 23 de marzo de 2022 A | 589 279 | 0 | 0 | $0 |
| Alison Moore | Chief Technical Officer | 23 de marzo de 2022 A | 120 430 | 0 | 0 | $0 |
| Stephen Mayo | Consejero | 18 de junio de 2026 A | — | 0 | 0 | $0 |
| Elizabeth A. Barrett | Consejero | 18 de junio de 2026 A | — | 0 | 0 | $0 |
| Deborah M. Messemer | Consejero | 18 de junio de 2026 A | 6 535 | 0 | 0 | $0 |
| Owen N. Witte | Consejero | 18 de junio de 2026 A | 233 271 | 0 | 0 | $0 |
| Franz B Humer | Consejero | 18 de junio de 2026 A | 191 892 | 0 | 0 | $0 |
| Joshua A Kazam | Consejero | 18 de junio de 2026 A | 398 463 | 0 | 0 | $0 |
| Vicki L Sato | Consejero | 18 de junio de 2026 A | 41 451 | 0 | 0 | $0 |
| Pfizer Inc. | Propietario del 10% | 15 de octubre de 2018 C | 22 032 040 | 0 | 0 | $0 |
| Earl Martin Douglas | — | 2 de febrero de 2026 A | 564 948 | 0 | 1 | $-40 304 |
| Arie Belldegrun | — | 2 de febrero de 2026 A | 4 710 120 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Pfizer Inc. | 13 de febrero de 2026 | 9,00% | Enmienda | — | SEC |
| Pfizer Inc. (“Pfizer”) ×3 presentaciones | 25 de octubre de 2023 | — | Presentación inicial | — | SEC |
| TPG GP A, LLC, David Bonderman, James G. Coulter, Jon Winkelried | 18 de enero de 2022 | — | Presentación inicial | — | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×4 presentaciones | 10 de agosto de 2020 | — | Presentación inicial | — | SEC |
| Pfizer Inc. (“ Pfizer ”) | 22 de octubre de 2018 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 30 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1,04% | 182 788 NS | 30 de abril de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,12% | 303 899 NS | 30 de abril de 2026 | N-PORT |
| BIB · ProShares Trust | 0,02% | 8 308 NS | 31 de mayo de 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 204 346 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 876 401 NS | 30 de abril de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 1 207 257 NS | 31 de mayo de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 7 333 NS | 31 de mayo de 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 5 734 NS | 31 de mayo de 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 5 798 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 146 NS | 31 de mayo de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4 797 NS | 31 de mayo de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 241 276 NS | 30 de abril de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 63 774 NS | 30 de abril de 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 149 554 NS | 31 de mayo de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 de julio de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| ITOT · iShares Trust | — | — | 4 de agosto de 2026 | Diario |
| IWV · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWN · iShares Trust | — | — | 17 de agosto de 2026 | Diario |
| IWM · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IBB · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 de julio de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13 de julio de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | — | — | 20 de julio de 2026 | Diario |
| SMLF · iShares Trust | — | — | 10 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 de julio de 2026 | Diario |